Mark Copley to discuss optimal testing methods for DPIs at inaugural Harro Höfliger symposium

21 January 2015; Nottingham, UK: Mark Copley, Sales Director for Copley Scientific, will discuss optimal in-vitro testing methods for dry powder inhalers (DPIs) at the inaugural Harro Höfliger Innovation Days symposium which is being run in cooperation with Capsugel. His invited presentation on 23rd February 2015 is part of a 2-day event that will cover all aspects of capsule-based DPI technology. The event takes place at the Hotel Sonne and Harro Höfliger Verpackungsmaschinen GmbH headquarters in Germany.

Mark Copley’s presentation will provide a basic introduction to the dose uniformity and aerodynamic particle size distribution methods required for the testing of orally inhaled products (OIPs), according to the requirements of USP, Ph. Eur., EMA and US FDA, with specific emphasis on DPIs. These tests are used for product development and into QC. DPIs, because of the way they operate, is arguably the most challenging OIP to test. Mr Copley will explain how to achieve robust and reliable test data for this important class of products, whether testing generics or new drug entities. To find out more or to register for the event, please visit:

During the symposium experts from academia and industry will deliver presentations and workshops on all aspects of capsule-based DPI technology, from powder characterisation and formulation to the devices used and capsule filling technology.

CAPTION: Mark Copley will present on in-vitro testing methods for DPIs at inaugural Harro Höfliger Innovation Days symposium (23-24th February 2015, Germany).

About Copley Scientific

Copley Scientific is recognised as the world’s leading manufacturer and supplier of inhaler test equipment and is a major provider of testing systems for other pharmaceutical dosage forms. The company is also active in detergent testing, air sampling and aerosol characterisation.

Copley Scientific’s pharmaceutical product range includes test equipment for delivered dose uniformity and aerodynamic particle size measurement of metered-dose inhalers, dry powder inhalers, nebulizers and nasal sprays; as well as tablets (dissolution, disintegration, friability and hardness) capsules, powders, suppositories and transdermals.

Copley Scientific has offices in the UK and Switzerland. The company works in partnership with aerosol particle science experts MSP Corporation in North America and also distributes MSP Corporation’s air sampling and aerosol characterisation products throughout Europe.

Serving the pharmaceutical and associated industries, Copley Scientific offers an extensive range of equipment for research, development and quality control, as well as full validation and aftersales services. This broad range of products is supplied and supported worldwide through a network of specialist distributors.